Member Info for Laura2022

Over £100k bought Friday

Let's see if that continues

No problem..

From my view as long as you accept the risks of a private company then it feels very good value at £2mln

Coris Refinancing Package

Hummingbird (HUM: AIM) is pleased to announce the completion of the strategic refinancing of a portion of its existing loan facilities with the Company's principal financing partner Coris Bank International ("Coris Bank").

The Group has secured a refinancing package amounting to approximately US$25 million at an annual interest rate of 12%. This new financing will be utilised to meet the Company's existing loan obligations due in Q2 2024, providing a two-year deferment of specific facilities currently held with Coris Ban

Potential value even as private Co

Sorcerer

Posts: 266

Price: 1.475

No Opinion

Current SP16 Aug 2024 19:56

Has absolutely nothing to do with the value of the company - how can a company with hundreds of millions of dollars worth of contracted revenue (not pipeline, CONTRACTED orders) be valued just £2m, which is less than half the value of cash they have, let alone their IP, cutting edge capabilities and the future value of those contracts (plus those yet to be announced).

The answer is uncertainty - the market, and PIs in particular, hate uncertainty and while the business has now likely turned the corner, the uncertainty about future returns to shareholders remains, which is why the SP is on its *rse. But sentiment is never a good way to value a business - fundamentals are - and that’s why, even with the shares now trading below 20% of what ROX paid for theirs in the placing (which BTW is considerably more than many PIs have paid if they’ve averaged down), they are still smiling. Why? Because they know what they have bought into here and they know that, even at 10p per share, it’s a ste

Dealing and settlement arrangements

The Directors are aware that certain Shareholders may wish to acquire or dispose of Ordinary Shares in the Company following the Cancellation.

Therefore, the Company has made arrangements for the Matched Bargain Facility to assist Shareholders to trade in the Ordinary Shares to be put in place from the day of Cancellation. The Matched Bargain Facility will be provided by J P Jenkins Limited ("JP Jenkins"). JP Jenkins is a liquidity venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).

Hope this helps aquarium

High chance this was Merck from June 2024 given the wording of KingH Merck summaries and what we already know about PYC/Merck

13 June 2024

 

Physiomics plc

("Physiomics" or the "Company")

 

Contract Award

 

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it has been awarded a new contract by an existing, large client. The project involves the use of our proprietary Virtual Tumour platform to model the client's targeted oncology agents in combination with other modalities to help inform dose and scheduling decisions

Would expect increasingly larger contracts from Merck

Physiomics plc (AIM: PYC), a leading mathematical modelling company, supporting development of oncology drugs and personalised medicine solutions, is pleased to announce that it has been awarded a further contract by existing client Merck KGaA that it expects to be completed over the next three months. The project will involve pre-clinical and clinical modelling and simulation of anti-cancer regimens involving combinations of DNA damage/ repair agents and follows on from previous projects commissioned by Merck KGaA.

 

Physiomics CEO, Dr Jim Millen, commented: "We are pleased that this longstanding client has once again chosen Physiomics as a partner for outsourced modelling. We look forward to the possibility of further projects with Merck during the current financial year."

Thanks once again Debull

Extremely relevant to PYC/merck alliance

From a digital health perspective, AI technology is “giving us superpowers for consolidation and synthesis of information,” Ozcan added.

He is also excited about the prospect of using AI technology to further enhance “hyper-personalization” of digital health tools.

Looking Ahead

Ozcan said there was no “golden recipe” for developing digital health tools, but Merck had focused on demonstrating value.

“The future is drug-digital combinations. It’s a very powerful tool."

Sums it up well paternoster

Porky

You've accused me (wrongly ) of being 3 different people (I've reported you to LSE everything and hence why you get banned for 1-6 days

Secondly

Slater was openly talking about the APTA need for a placing while selling before and after his TR1 in May , knowing full well via his mates AH there was a fund raise..( he started his unhappiness with the BOD publicly on X during June and July)

Good look in APTA as hopefully it's a good turnaround

Porky

You at universally known as a pathetic vindictive lair

Ask VAL APTA NCYT DDDD NEOS etc

You've joined LSE for a couple of days and immediately posted 7+ things which make no sense OR which have bee a answered in the recent RNSs (which I assume you've read and I assume you hold shares here?)

Have you actually read the circular ?

It explains everything in there

Make mine etc

There's no way all those buys weren't from people on the inside

Latino

Look at all the block buys for last 4hrs

MMs are facilitate a buyer here

To come

Over 2mln bought in round trades last 3hrs

Fantastic kingh

It'd certainly creeping up day by day